Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Green Jeremy
Relationship:   Former 10% Owner and D...
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   31    
Direct Shares   49,793    

Indirect Shares

  116,486,068      
Direct Value   $270,376    

Indirect Value

  $325,158,271      
Total Shares   116,535,861      
Total Value   $325,428,647      


Syros Pharmaceuticals, Inc.
 $270,376 Syros Pharmaceuticals, Inc.
 $270,376
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    9   
    1    

     Stock price went up :

    2   
    0    
     Stock price went down :
    7   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.9%
 -38.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amicus Therapeutics Inc FOLD 10% Owner 2016-06-03 0 2016-06-03 12,956,446    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2016-07-06 49,793 2016-07-06 0    Premium*  
            Xeris Pharmaceuticals Inc XERS 10% Owner 2018-06-25 0 2019-02-19 3,000,642    Premium*  
            Allakos Inc. ALLK 10% Owner 2018-07-23 0 2018-07-23 1,009,090    Premium*  
            Replimune Group Inc REPL 10% Owner 2018-07-24 0 2018-07-24 779,655    Premium*  
            Fate Therapeutics Inc FATE Director, 10% Owner 2018-09-25 0 2023-12-26 13,180,388    Premium*  
            Gritstone Oncology, Inc. GRTS 10% Owner 2018-10-02 0 2018-10-02 1,394,529    Premium*  
            Vapotherm Inc VAPO 10% Owner 2018-11-16 0 2018-11-16 959,540    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2019-02-19 0 2019-02-19 807,256    Premium*  
            Alder Biopharmaceuticals Inc ALDR Director 2019-03-04 0 2019-10-22 0    Premium*  
            Akero Therapeutics, Inc. AKRO 10% Owner 2019-06-24 0 2019-06-24 743,802    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 715,306    Premium*  
            Stoke Therapeutics, Inc. STOK 10% Owner 2019-06-21 0 2019-06-21 671,808    Premium*  
            Igm Biosciences, Inc. IGMS 10% Owner 2019-09-20 0 2024-03-29 3,078,332    Premium*  
            Aprea Therapeutics, Inc. APRE 10% Owner 2019-10-07 0 2020-12-28 1,768,718    Premium*  
            Cabaletta Bio, Inc. CABA 10% Owner 2019-10-29 0 2019-10-29 696,378    Premium*  
            Beam Therapeutics Inc. BEAM 10% Owner 2020-02-10 0 2020-02-10 1,161,458    Premium*  
            Neurogene NGNE 10% Owner 2020-03-27 0 2020-04-02 4,041,211    Premium*  
            Pliant Therapeutics, Inc. PLRX 10% Owner 2020-06-05 0 2020-06-05 1,910,657    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2020-06-23 1,586,174    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2020-07-28 0 2020-07-28 1,176,470    Premium*  
            Annexon, Inc. ANNX 10% Owner 2020-07-28 0 2020-07-28 1,596,222    Premium*  
            Allovir Inc ALVR 10% Owner 2020-08-03 0 2020-08-03 823,371    Premium*  
            Kymera Therapeutics, Inc. KYMR 10% Owner 2020-08-25 0 2020-08-25 1,630,660    Premium*  
            Augmedix, Inc AUGX Director, 10% Owner 2020-10-05 0 2024-03-15 16,408,909    Premium*  
            Shattuck Labs, Inc. STTK Director, 10% Owner 2020-10-14 0 2024-03-28 5,615,489    Premium*  
            MedAvail Holdings, Inc MDVL Director, 10% Owner 0 2022-04-04 25,192,751    Premium*  
            Verve Therapeutics, Inc. VERV 10% Owner 2021-06-21 0 2021-06-21 1,936,530    Premium*  
            Absci Corp ABSI Director 2021-07-26 0 2024-03-01 8,253,316    Premium*  
            Adagio Therapeutics, Inc. ADGI 10% Owner 2021-08-10 0 2021-08-10 3,390,960    Premium*  
            Science 37 Holdings, Inc SNCE Former 10% Owner and D... 2021-10-06 0 2024-03-12 0    Premium*  
* Premium Members only  

Records found :    110         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ABSI Absci Corp Director   –       •      –    2021-07-26 4 B $16.00 $30,000,000 I/I 1,875,000 8,031,094 2.1 %
ABSI Absci Corp Director   –       •      –    2021-07-26 4 A $0.00 $0 I/I 6,156,094 6,156,094 0 -
ABSI Absci Corp Director   –       •      –    2024-03-01 4 B $4.50 $999,999 I/I 222,222 8,253,316 2.1 %
ADGI Adagio Therapeutics, Inc. 10% Owner   –       –       •   2021-08-10 4 B $17.00 $24,990,000 I/I 1,470,000 3,390,960 1.5 %
ADGI Adagio Therapeutics, Inc. 10% Owner   –       –       •   2021-08-10 4 A $0.00 $0 I/I 1,920,960 1,920,960 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2019-06-24 4 A $0.00 $0 I/I 743,802 743,802 0 -
ALDR Alder Biopharmaceuticals ... 10% Owner   –       –       •   2019-03-04 4 A $11.50 $19,999,995 I/I 1,739,130 8,244,896 0 -
ALDR Alder Biopharmaceuticals ... Director   –       •      –    2019-10-22 4 D $0.00 $0 I/I (8,244,896) 0 0 -
ALLK Allakos Inc. 10% Owner   –       –       •   2018-07-23 4 A $0.00 $0 I/I 1,009,090 1,009,090 0 -
ALVR Allovir Inc 10% Owner   –       –       •   2020-08-03 4 A $0.00 $0 I/I 823,371 823,371 0 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2016-06-03 4 B $7.20 $477,360 I/I 66,300 12,956,446 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2016-06-03 3 IO $0.00 $0 I/I 0 12,890,146 -
ANNX Annexon, Inc. 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 I/I 1,596,222 1,596,222 0 -
APRE Aprea Therapeutics, Inc. 10% Owner   –       –       •   2019-10-07 4 B $15.00 $6,000,000 I/I 400,000 2,268,718 1.5 -
APRE Aprea Therapeutics, Inc. 10% Owner   –       –       •   2019-10-07 4 A $0.00 $0 I/I 1,868,718 1,868,718 0 -
APRE Aprea Therapeutics, Inc. 10% Owner   –       –       •   2020-12-28 4 S $5.58 $2,791,290 I/I (500,000) 1,768,718 0 -
BCEL Atreca Inc 10% Owner   –       –       •   2019-06-24 4 A $0.00 $0 I/I 715,306 715,306 0 -
AUGX Augmedix, Inc Director   –       •       •   2020-10-05 4 B $3.00 $15,000,000 I/I 5,000,000 12,755,327 2.25 -
AUGX Augmedix, Inc Director   –       •       •   2020-10-05 3 IO $0.00 $0 I/I 0 7,755,327 -
AUGX Augmedix, Inc Director   –       •       •   2023-04-19 4 A $1.60 $2,000,000 I/I 1,250,000 15,630,327 0 -
AUGX Augmedix, Inc Director   –       •       •   2023-07-13 4 A $0.00 $0 I/I 21,598 15,651,925 0 -
AUGX Augmedix, Inc Director   –       •       •   2023-08-31 4 A $4.78 $10,000 I/I 2,092 15,654,017 0 -
AUGX Augmedix, Inc Director   –       •       •   2023-12-15 4 A $0.00 $0 I/I 1,767 16,405,784 0 -
AUGX Augmedix, Inc Director   –       •       •   2024-03-15 4 A $0.00 $0 I/I 3,125 16,408,909 0 -
BEAM Beam Therapeutics Inc. 10% Owner   –       –       •   2020-02-10 4 A $0.00 $0 I/I 1,161,458 1,161,458 0 -

  110  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed